The U.S. Pharmacopeia (USP) and Mestrelab Research, S.L. (Mestrelab)

FHS
April 18, 2024
12:54 pm

The U.S. Pharmacopeia (USP) and Mestrelab Research, S.L. (Mestrelab), are pleased to announce they have entered into a collaboration to deliver USP-ID, through Mestrelab’s Mnova platform.

A novel biomonitoring method reveals neurotoxic chemical mixtures in human blood

Studies of chemicals in our blood typically capture only a small and unknown fraction of the entire chemical universe. Now, a new approach aims to

October 18, 2024

Study offers insights into factors influencing older adults to stop driving

What factors lead older adults to stop driving? A new study followed older adults who had no memory or thinking problems to examine this question.

May 23, 2024

Q&A: The new CEO of biotech’s top trade group on China, vaccines, and Trump

Rachel Cohrs Zhang Chief Washington Correspondent Rachel Cohrs Zhang reports on the intersection of health policy and business in Washington. She covers Capitol Hill, lobbying,

July 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.